Search for: "GLAXOSMITHKLINE" Results 61 - 80 of 1,808
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Mar 2022, 10:50 am by Katherine Pompilio
The Justice Department will reportedly probe at least a dozen pharmaceutical companies such as Gilead Sciences Inc, Johnson & Johnson and GlaxoSmithKline PLC’s ViiV Healthcare. [read post]
24 Mar 2022, 6:02 am by Searcy Law
” Basically, this was a win for Avandia’s manufacturer, GlaxoSmithKline—a win for which the manufacturer no doubt fought hard and spent millions of dollars. [read post]
24 Mar 2022, 6:02 am by Searcy Law
” Basically, this was a win for Avandia’s manufacturer, GlaxoSmithKline—a win for which the manufacturer no doubt fought hard and spent millions of dollars. [read post]
24 Mar 2022, 6:02 am by Searcy Law
” Basically, this was a win for Avandia’s manufacturer, GlaxoSmithKline—a win for which the manufacturer no doubt fought hard and spent millions of dollars. [read post]
15 Feb 2022, 9:03 pm by Patent Docs
Federal Circuit Denies En Banc Review in GlaxoSmithKline LLC v. [read post]
14 Feb 2022, 9:38 am by Dennis Crouch
by Dennis Crouch GlaxoSmithKline LLC v. [read post]
11 Feb 2022, 10:15 am by Steve Brachmann
This week in Other Barks & Bites: the The Federal Circuit denies rehearing in Teva's case with GlaxoSmithKline’s regarding Teva's induced infringement of a GSK patent directed to a method of treating Congestive Heart Failure; the Eleventh Circuit affirms that press release statements regarding patent licensing and other business activities by Revolutionary Concepts included false statements violating federal securities law; the World Intellectual Property Organization… [read post]
11 Feb 2022, 10:15 am by Steve Brachmann
This week in Other Barks & Bites: the The Federal Circuit denies rehearing in Teva's case with GlaxoSmithKline’s regarding Teva's induced infringement of a GSK patent directed to a method of treating Congestive Heart Failure; the Eleventh Circuit affirms that press release statements regarding patent licensing and other business activities by Revolutionary Concepts included false statements violating federal securities law; the World Intellectual Property Organization… [read post]
27 Dec 2021, 4:00 am by Moll Law Group
On October 8th, a federal judge presiding over the Zantac multidistrict litigation ruled that the brand manufacturers of Zantac — GlaxoSmithKline, Sanofi, Pfizer, and Boehringer Ingelheim — should face lawsuits by people formerly prescribed the drug. [read post]
16 Dec 2021, 3:30 pm by Sabrina I. Pacifici
Sotrovimab, a treatment from Vir Biotechnology and GlaxoSmithKline, is expected to remain effective against omicron.. [read post]
18 Nov 2021, 3:00 am by Brian
In a Zantac case, the defendant who is required to pay damages when the damages have been proven is typically a pharmaceutical company like GlaxoSmithKline, Novartis, or Sanofi, all of which manufacture Zantac and other ranitidine products, but it is also possible to successfully sue others in the supply chain. [read post]
18 Nov 2021, 3:00 am by Brian
In a Zantac case, the defendant who is required to pay damages when the damages have been proven is typically a pharmaceutical company like GlaxoSmithKline, Novartis, or Sanofi, all of which manufacture Zantac and other ranitidine products, but it is also possible to successfully sue others in the supply chain. [read post]
18 Nov 2021, 3:00 am by Brian
In a Zantac case, the defendant who is required to pay damages when the damages have been proven is typically a pharmaceutical company like GlaxoSmithKline, Novartis, or Sanofi, all of which manufacture Zantac and other ranitidine products, but it is also possible to successfully sue others in the supply chain. [read post]
4 Nov 2021, 7:03 pm by Edward T. Kang and Ryan T. Kirk
This trend is particularly evident in the pharmaceutical sector, where violations of the FCA have forced corporate behemoths like GlaxoSmithKline and Pfizer into billion-dollar settlements. [read post]
14 Oct 2021, 4:15 am by Gretchen Miller
The Federal Circuit’s recent majority opinion and Chief Judge Prost’s dissenting opinion in the GlaxoSmithKline LLC v. [read post]
14 Oct 2021, 4:15 am by Gretchen Miller
The Federal Circuit’s recent majority opinion and Chief Judge Prost’s dissenting opinion in the GlaxoSmithKline LLC v. [read post]
30 Sep 2021, 8:50 am by Tim De Chant
Initially, Celgene and another pharmaceutical company, GlaxoSmithKline, were intrigued by the promise of Theranos’ devices. [read post]
28 Sep 2021, 7:37 am by Ronald V. Miller, Jr.
But projecting settlement amounts is what stock analysts and shareholders for Sanofi-Aventis, Boehringer Ingelheim, Pfizer, and GlaxoSmithKline are already doing and baking those costs into the stock price. [read post]
28 Sep 2021, 7:37 am by Ronald V. Miller, Jr.
GlaxoSmithKline originally developed and released Zantac but it was widely available in generic versions manufactured by various companies. [read post]